Experienced FMCG entrepreneur with over 9 years spent in brand and product development, particularly in mainstream grocery channels;
International Business Experience with the ACT Government;
Launched a number of consumer goods brands in the Australian Market.
Geoff Starr
Non-Executive Chairman
32 years’ experience building and transforming businesses in household, food, chemical, agribusiness and pet care: 9 years in senior executive roles at MARS Global Pet care; 13 years in Asia, 10 years global experience, including USA and Europe;
Executive positions including, Unilever, George Western Foods.
Dr Kate Adams
Non-Executive Director
Co-owner of Bondi Veterinary Hospital and Founder of tech startup, Thankly;
Held senior leadership roles for the Federal Attorney-General’s Portfolio including as Analyst, Principal Adviser and Chief of Staff for a number of Royal Commissions;
Bachelor of Science, Masters of Data Analytics, Bachelor of Veterinary Medicine and Surgery.
Robert Clifford
Non-Executive Director
Over 20 years of experience in Brand implementation and Business Strategy and Planning
Senior leadership roles in large multinational private and public corporations in Australia, China and Ireland
Former President of the Irish Australian Chamber of Commerce
Invest in CannPal
CannPal Animal Therapeutics Limited (“CannPal”) is a pharmaceutical-focused animal health company researching the benefits of medical cannabis for companion animals. The company is listed on the Australian Stock Exchange (ASX) in 2017, trading under the ASX ticker “CP1”. CannPal was founded to research, develop and commercialise, regulatory approved medicines derived from the medical cannabis plant to provide veterinarians with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.